The pulmonary physician in critical care • Illustrative case 6: Acute chest syndrome of sickle cell anaemia

Thorax

Volumn 58, Issue 8, 2003, Pages 726-728

  Mak, V ^a   Davies, S C ^a  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; NITRIC OXIDE; OPIATE;

ACUTE CHEST SYNDROME; ADULT; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; BRONCHUS BIOPSY; CANCER PAIN; CASE REPORT; DISEASE COURSE; HUMAN; INTENSIVE CARE; LABORATORY TEST; MALE; PATHOPHYSIOLOGY; PATIENT CARE; PHYSICIAN; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SEROLOGY; SICKLE CELL ANEMIA; THORAX RADIOGRAPHY;

ACUTE DISEASE; ADULT; ANEMIA, SICKLE CELL; CHEST PAIN; COUGH; CRITICAL CARE; DYSPNEA; FEVER; HUMANS; LUNG DISEASES; MALE; SYNDROME; THROMBOEMBOLISM;

EID: 0042622441     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.8.726     Document Type: Review

References (29)

1. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000;342:1855-65.
2. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. Blood 1994;84:643-9.
3. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-44.
4. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-6.
5. Aquino SL, Gamsu G, Fahy JV, et al. Chronic pulmonary disorders in sickle cell disease: findings at thin section CT. Radiology 1994;193:807-11.
6. Ingram VM. Gene mutations in human hemoglobin: the chemical difference between normal and sickle cell hemoglobin. Nature 1957;180:326-8.
7. Setty BN, Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 1996;88:2311-20.
8. Vichinsky EP, Williams R, Das M, et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994;83:3107-12.
9. Styles LA, Schalkwijk CG, Aarsman AJ, et al. Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood 1996;87:2573-8.
10. Styles LA, Aarsman AJ, Vichinsky EP, et al. Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood 2000;96:3276-8.
11. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood 1999;94:1555-60.
12. Head C, Brugnara AC, Martinez-Ruiz R, et al. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest 1997;100:1193-8.
13. Dweik R, Laskowski AD, Abu-Soud HM, et al. Nitric oxide synthesis in the lung: regulation by oxygen through a kinetic mechanism. J Clin Invest 1998;101:660-6.
14. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
15. Deem S, Swenson ER, Alberts MK e, et al. Red-blood-cell augmentation of hypoxic pulmonary vasoconstriction: haematocrit dependence and the importance of nitric oxide. Am J Respir Crit Care Med 1998;157:1181-6.
16. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the Frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-22.
17. Platt OS, Orkin SH, Dover G, et al. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest 1984;74:652-6.
18. Rodgers GP, Dover GJ, Noguchi CT, et al. Hematologic responses of patients with sickle cell disease to treament with hydroxyurea. N Engl J Med 1990;322:1037-45.
19. Styles LA, Lubin B, Vichinsky E, et al. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood 1997;89:2554-9.
20. Adragna NC, Fonseca P, Lauf PK. Hydroxyurea affects cell morphology, cation transport, and red cell adhesion in cultured vascular endothelial cells. Blood 1994;83:553-60.
21. Pacelli R, Taira J, Cook JA, et al. Hydroxyurea reacts with heme proteins to generate NO. Lancet 1996;347:900.
22. Glover RE, Ivy ED, Orringer EP, et al. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea. Mol Pharmacol 1999;55:1006-10.
23. Vichinsky EP, Styles LA, Colangelo LH, et al. Acute chest syndrome in sickle cell disease: clinical presentation and course. Blood 1997;89:1787-92.
24. Bellet PS, Kalinyak KA, Shukla R, et al. Incentive spirometry to prevent acute pulmonary complications in sickle cell disease. N Engl J Med 1995;333:699-703.
25. Wayne AS, Kevy SV, Nathan D. Transfusion management of sickle cell disease. Blood 1993;81:1109-23.
26. Emre U, Miller ST, Gutierez M. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr 1995;127:901-4.
27. Cranshaw J, Griffiths MJD, Evans TW. The pulmonary physician in critical care-9: Non-ventilatory strategies in ARDS. Thorax 2002;57:823-9.
28. Atz AM and Wessel DL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 1997;87:988-90.
29. Sullivan KJ, Goodwin SR, Evangelist J, et al. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med 1999;27:2563-8.